Orthobiologics

DePuy Synthes and LifeNet launched ViviGen Formable™ Cellular Bone Matrix, next-gen allograft to support bone formation during spinal fusion....

Zimmer Biomet announced FDA approval of an expanded 26-week efficacy claim for single-injection Gel-One® Cross-linked Hyaluronate viscosupplement for the treatment of knee...

Vericel announced the first U.S. implant of MACI® autologous cultured chondrocytes for the treatment of symptomatic knee cartilage defects....

SIRAKOSS was granted two U.S. patents covering synthetic bone graft technologies, and seeks to raise £3.5MM to £5.0MM in support of...

Results from Phase I and Phase II study indicate that Histogenics’ NeoCart® tissue-engineered implant is a safe, effective treatment for articular...

CartiHeal received FDA approval of its Investigational Device Exemption application submitted for the Agili-C™ implant, in support of a Premarket Approval application....

Anika Therapeutics received CE Mark approval for ORTHOVISC®-T injection indicated to relieve pain and restore function in tendons affected by chronic...

OrthoTrophix announced results of the first proof of principle study of TPX-100 in bilateral knee osteoarthritis, showing improvements at 6 and 12 months in...

SpinalCyte received IRB approval to commence Phase I clinical trials with its CybroCell dermal fibroblast cell product in the treatment...

Zimmer Biomet launched PrimaGen Advanced™ Allograft, an autograft substitute comprising cancellous bone + demineralized cortical bone fibers with verified osteoinductivity....